FDA approves pediatric neuroblastoma drug based on Penn State professor’s work
Giselle Saulnier Sholler, professor of pediatrics and of pharmacology, reflects on 20 years working to change cancer outcomes for children HERSHEY, Pa. — In 2003, the first year of her[...]
US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer
LOUISVILLE, Ky.--(BUSINESS WIRE)--USWM, LLC (US WorldMeds) today announced that the U.S. Food and Drug Administration (FDA) has approved IWILFIN™ (eflornithine) 192 mg tablets, a groundbreaking oral maintenance therapy for high-risk[...]
Penn State Health recruits leading researcher to fight pediatric cancer
Cris Collingwood//August 2, 2023 An internationally known physician-scientist and her research consortium have joined Penn State Health to continue efforts to eradicate pediatric cancer. Penn State Health and Penn State College of Medicine[...]
The Power of Will
Will Lacey was just a baby when doctors diagnosed a rare form of cancer and told his family there was only one end. Nobody then could imagine the journey ahead,[...]
Michigan Child Trials Target Genetic Roots of Cancers
Thank you Detroit News for featuring a story about the work we are doing. It wouldn’t be possible without the support of Dell, TGen Foundation and our generous community. Together,[...]
$1,100,000 for Beat Childhood Cancer Research!
On December 24, 2014 the Grand Rapids community surpassed the Million Dollar Challenge by raising $1,100,000 for NMTRC research! This donation was then matched by a generous Beat NB donor[...]
Endowment Gift Establishes Haworth Family Pediatric Oncology Innovative Therapeutics Clinic at Helen Devos Children’s Hospital
Children fighting cancer have new hope thanks to an endowment gift from Dick and Ethie Haworth to the Helen DeVos Children’s Hospital Foundation. Their major gift establishes the Haworth Family[...]
Research: Beat Childhood Cancer
The Beat Childhood Cancer Research Consortium is a group of 54+ universities and children's hospitals
Thank you to our BCC Bioinformatician, Abhinav Nagulapally, and Dr. Chandrika Behura for representing us at the American Association for Cancer Research (AACR) Conference this week!
They presented a poster on Casein Kinase II (CK2) expression across pediatric solid tumors (neuroblastoma, Ewing sarcoma, and rhabdomyosarcoma) using our IN:Formation Project Database of > 700 pediatric tumors. We are on track for a trial to open this year targeting this pathway!
Thank you to all of our donors that support BCC and the IN:Formation Project to be able to move this data forward!
Beat Childhood Cancer Foundation Team Parker for Life Summer's Way Foundation Little Warrior Foundation Maddie’s Promise Move For Jenn Foundation Mighty Millie Foundation Maxwell James Oskam Foundation Brooke's Blossoming Hope for Childhood Cancer Foundation, among others!
BCC Research Consortium has two posters being presented at The American Society of Pediatric Hematology/Oncology (ASPHO) Conference in Seattle, WA this week!
1. End of Induction Response Correlates with Clinical Outcome in Patients with High-Risk Neuroblastoma (HRNB)
2. Assessment of Household Poverty Exposure in HRNB Receiving DFMO Maintenance Treatment
Thank you Dr. Bill Ferguson and Dr. Valerie Brown for representing us at the conference!
We were honored to host Sharyn and Lisa from Milan's Miracle Fund for a lab tour and research update with our team last week. Thank you for continuing to support Diffuse Intrinsic Pontine Glioma (DIPG) research in honor of Milan and so many other children across the country!
Our Beat Childhood Cancer Research Consortium 16th Annual Meeting happened Feb 28-March 1 at the sweetest place on earth! This conference brings together physicians and coordinators from our 50+ hospitals across the US and Canada as well as donors, advocates, research collaborators and industry sponsors.
It is so important to have these meetings to reflect on what accomplishments were made in 2023 and what plans and goals the Consortium has for 2024! It is invaluable to meet in person to exchange ideas, design research projects, and push the boundaries of what we can do as a group.
We want to thank everyone that attended this year both in person and virtually and we hope to see you there next year!
#beatchildhoodcancer #pediatriccancerresearch
www.carislifesciences.com/about/news-and-media/beat-childhood-cancer-research-consortium-partners...
“The Beat Childhood Cancer Research Consortium is excited to collaborate with Caris to expand our precision medicine program. We believe that sequencing all patients tumors, as well as following circulating tumor DNA in the blood and molecular tumor board review, will improve the depth and accuracy of our patient care. This is an important step in the future of cancer care for children”
Caris Partners with Beat Childhood Cancer Research Consortium
www.carislifesciences.com
Caris Life Sciences Partners with Beat Childhood Cancer Research Consortium to Improve Outcomes for Pediatric Patients
Last week, the Beat Childhood Cancer Research Consortium Annual Meeting was held in Hershey, Pa.
Giselle Saulnier Sholler, MD, director of pediatric oncology research at Penn State College of Medicine, and her team presented multiple clinical trials that are focused on helping children battling cancer — children like Parker Shaw, who was diagnosed with neuroblastoma a decade ago in 2014.
Parker is now a surfer, hoping to achieve a career as a sheriff following graduation from high school. Read his story by Local 21 CBS News, WHP Harrisburg here: bit.ly/48EX9Tx
